NANCY ALLEN: Open Payments
NPI 1992062574 · LONE TREE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$780 in 32 payments from 9 companies in 2025. Trend: 2023 $495 · 2024 $1,012 · 2025 $780
Food & beverage: $780
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 8 | $287 |
| Alkermes, Inc. | 7 | $163 |
| E.R. Squibb & Sons, L.L.C. | 7 | $150 |
| ABBVIE INC. | 3 | $61 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: INGREZZA, COBENFY, LYBALVI, VRAYLAR, REXULTI, CAPLYTA, ABILIFY MAINTENA, ZEPBOUND.
Industry payments across CO — which companies pay providers there.
